Overview
Cathy Maclean practices practicing medicine in London, United Kingdom.
Her clinical expertise encompasses Essential Thrombocythemia, Myeloproliferative Neoplasms (MPN), and Blood Clots.
She is actively involved in clinical research, co-authoring 8 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Cathy Maclean
Is Cathy Maclean a top-rated expert for Essential Thrombocythemia?
MediFind is an objective health platform that identifies experts based on real-world data. Cathy Maclean is classified as an Experienced expert for Essential Thrombocythemia, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Cathy Maclean participate in research or clinical trials?
Yes. Cathy Maclean has published 8 articles and abstracts on conditions like Essential Thrombocythemia. You can view a list of Cathy Maclean's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Blood ClotsMs. Maclean isExperienced. Learn about Blood Clots.
- Essential ThrombocythemiaMs. Maclean isExperienced. Learn about Essential Thrombocythemia.
- Myeloproliferative Neoplasms (MPN)Ms. Maclean isExperienced. Learn about Myeloproliferative Neoplasms (MPN).